×
DaVita Revenue 2010-2024 | DVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
DaVita revenue for the twelve months ending September 30, 2024 was
$12.667B
, a
6.34% increase
year-over-year.
DaVita annual revenue for 2023 was
$12.14B
, a
4.57% increase
from 2022.
DaVita annual revenue for 2022 was
$11.61B
, a
0.08% decline
from 2021.
DaVita annual revenue for 2021 was
$11.619B
, a
0.59% increase
from 2020.
View More
DaVita Revenue 2010-2024 | DVA
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
DaVita annual revenue for 2023 was
$12.14B
, a
4.57% increase
from 2022.
DaVita annual revenue for 2022 was
$11.61B
, a
0.08% decline
from 2021.
DaVita annual revenue for 2021 was
$11.619B
, a
0.59% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$20.9B
Quest Diagnostics (DGX)
$16.9B
Encompass Health (EHC)
$9.5B
Chemed (CHE)
$8.3B
Elanco Animal Health (ELAN)
$5.9B
Option Care Health (OPCH)
$5B
RadNet (RDNT)
$4.4B
LifeStance Health (LFST)
$3.1B
Amedisys (AMED)
$3B
Addus HomeCare (ADUS)
$2.4B
Astrana Health (ASTH)
$2B
U.S Physical Therapy (USPH)
$1.3B
Pennant (PNTG)
$943M
Aveanna Healthcare Holdings (AVAH)
$899M
Atai Life Sciences (ATAI)
$245M
Bioqual (BIOQ)
$58M
Daxor (DXR)
$41M
Ontrak (OTRK)
$7M
MEDIROM Healthcare Technologies (MRM)
$5M
IMAC Holdings (BACK)
$3M
Psychemedics (PMD)
$0M